Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aptevo Therapeutics Inc. Director's Dealing 2019

Jun 7, 2019

35422_dirs_2019-06-07_0988c082-e21c-45df-8986-c99b2d5f5898.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-05-31

Reporting Person: Maddux Randy Joe (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-31 Common Stock P 20000 $0.73 Acquired 50000 Direct